论文部分内容阅读
目的 :探讨小儿肺咳合剂对儿童咳嗽变异性哮喘的临床治疗效果。方法 :从2014年4月-2015年4月期间收治的儿童咳嗽变异性哮喘患者中筛选出56例,按照病历号分为两组,单数为实验组,双数为对照组,每组28例。对照组患者给予孟鲁司特钠咀嚼片和硫酸特布他林进行治疗,实验组患者在对照组基础上联合小儿肺咳合剂进行治疗。治疗结束后对比两组患者的治疗效果。结果:实验组患儿治疗的总有效率为96.4%,而对照组仅为82.1%,两组具有明显差异,P<0.05。结论 :小儿肺咳合剂对儿童咳嗽变异性哮喘具有良好的治疗效果,值得在临床治疗中推广应用。
Objective: To investigate the clinical therapeutic effect of Xiaoerfeihuikang on children with cough variant asthma. Methods: Fifty-six children with cough variant asthma were selected from April 2014 to April 2015. The patients were divided into two groups according to the medical record number. The single group was experimental group and the double was the control group, with 28 cases in each group . Patients in the control group were given montelukast sodium chewable tablets and terbutaline sulphate for treatment. Patients in the experimental group were treated with the combination of pediatric lung cough mixture on the basis of the control group. After treatment, the treatment effect of two groups of patients was compared. Results: The total effective rate of treatment group was 96.4%, while that of control group was only 82.1%. There was a significant difference between the two groups (P <0.05). Conclusion: Xiaoerfeikang Mixture has a good therapeutic effect on children with cough variant asthma, which is worth to be popularized in clinical treatment.